Full-Time

Enterprise Partnerships Lead

Strategic Partnerships

Luminai

Luminai

51-200 employees

Converts SOPs into automated enterprise workflows

Compensation Overview

$300k - $400k/yr

San Francisco, CA, USA + 1 more

More locations: New York, NY, USA

Hybrid

Four days in-office per week; Wednesday is optional work from home. Travel to customers, conferences, and the San Mateo office is expected 1–2 weeks per month.

Category
Sales & Account Management (1)
Required Skills
CRM
Data Governance
Data Analysis

Get referred to Luminai

See people who can refer or advise you

Requirements
  • You have 7+ years of experience successfully selling enterprise software, including artificial intelligence, analytics, or software as a service, to C-suite healthcare executives at large health systems.
  • You are an expert in driving complex sales cycles lasting 6–12 months, involving multiple stakeholders, competitive dynamics, and sophisticated contract negotiations.
  • You consistently achieve seven-figure quota attainment with a strong win rate and close seven-figure contracts.
  • You are intellectually curious about artificial intelligence, can translate technology into business value, and are opinionated about how it can transform healthcare.
  • You are excited to travel 25% or more to meet customers and the team in person.
Responsibilities
  • Own the full enterprise sales cycle from prospecting and discovery through contracting, delivery, and expansion.
  • Develop and influence executive-level relationships with CIOs, CDOs, CROs, revenue cycle management, Patient Access, Legal, and Compliance stakeholders to drive buy-in, deal success, and shared operational outcomes.
  • Navigate complex procurement and contracting processes, including legal, security, compliance, and data governance.
  • Leverage marketing resources and strategies to generate new opportunities and accelerate account progress through tradeshows, events, and targeted campaigns.
  • Communicate Luminai’s value and return on investment effectively to business and information technology executives, adapting messaging to diverse audiences.
  • Help drive the go-to-market and sales strategy, playbook, process, and approach.
  • Travel 1–2 weeks per month to customers, conferences, and the San Mateo office if not based in California.

Luminai provides AI-powered automation for large organizations. Its platform lets enterprises upload Standard Operating Procedures (SOPs), which the system analyzes to generate automated, one-click workflows. These workflows execute tasks by simulating keyboard and mouse actions, helping ensure compliance and strong security. The product is offered on a subscription basis, with potential add-ons for custom integrations or premium support. Luminai serves sectors like healthcare, consumer, and financial services, focusing on automating manual, repetitive processes across enterprise-level operations. Its goal is to reduce operational costs and increase efficiency by eliminating the need for manual intervention in routine tasks, enabling organizations to run more work with less human input.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.4M

Headquarters

Palo Alto, California

Founded

2019

Get referred to Luminai

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Luminai raised $38 million in April 2026, reaching $60 million total capital.
  • Cleveland Clinic partnership opens a massive reference account across 23 hospitals.
  • Referral management and fax routing target immediate pain, with documented 48-day time-to-value.

What critics are saying

  • Healthcare focus concentrates revenue on one regulated vertical and one buying cycle.
  • Cleveland Clinic dependence creates concentration risk if rollout stalls after 2026.
  • UiPath, Automation Anywhere, and EHR-native vendors can bundle similar workflows faster.

What makes Luminai unique

  • Luminai sells healthcare-first workflow automation, not generic horizontal RPA, since 2026.
  • Its platform converts unstructured faxes into structured actions, with Cleveland Clinic validation.
  • Forward-deployed teams deliver results in weeks, beating 18-to-24-month enterprise software cycles.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare benefits

Flexible PTO

Financial planning support

Parental leave

L&D stipend

Stipends for mental & physical wellness

Workstation setup, laptop included

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

-5%

2 year growth

-3%
Forbes
Apr 9th, 2026
Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations

The challenge for health systems now is finding an AI partner that can scale across use cases. That is the backdrop for Cleveland Clinic’s partnership with Luminai.

Yahoo Finance
Apr 9th, 2026
Cleveland Clinic partners with Luminai to automate healthcare workflows after $38M Series B

Cleveland Clinic has partnered with Luminai, a San Francisco-based AI startup, to automate complex administrative healthcare workflows. The collaboration coincides with Luminai's $38 million Series B funding round, bringing total capital raised to approximately $60 million, with backing from Peak XV Partners, General Catalyst, Define Ventures and Y Combinator. The health system, which employs over 80,000 staff across 23 hospitals, selected Luminai to address administrative burdens that account for roughly a quarter of US healthcare spending. Initial deployment focuses on referral management, where Cleveland Clinic processes thousands of daily faxes requiring manual review and routing. "The goal is to reduce administrative burden and allow our caregivers to focus on patient care," said Rohit Chandra, Cleveland Clinic's chief digital officer. The partnership reflects growing pressure on health systems to modernise operations whilst managing workforce shortages and rising costs.

PR Newswire
Apr 9th, 2026
Luminai raises $38M Series B to scale AI-native healthcare operations platform

Luminai, an AI-native enterprise automation platform for healthcare operations, has raised $38 million in a Series B round led by Peak XV Partners, bringing total funding to $60 million. Define Ventures joined as a new investor, with General Catalyst and Y Combinator continuing their backing. The San Francisco-based company addresses healthcare's administrative burden, which accounts for significant industry costs through fragmented systems and manual processes. Luminai's platform applies healthcare-trained AI to interpret unstructured data and coordinate end-to-end workflows across access, revenue cycle and compliance functions. Founded by Kesava Kirupa Dinakaran, the company employs talent from Palantir, Cruise, Google and Epic. The funding will expand product capabilities, grow engineering and deployment teams, and support additional enterprise customers as health systems seek scalable operational modernisation solutions.

General Catalyst
Feb 23rd, 2026
Our Investment in Luminai

We originated new companies from scratch to address the world’s unmet needs.

PR Times
Feb 13th, 2026
NYC invests in Lluminai, AI startup transforming Japan's manufacturing sector

NYC Corporation, a Tokyo-based investment firm focused on business succession and growth support for small and medium enterprises, has executed a minority investment in Luminai Corporation, a startup developing AI solutions and products for the manufacturing sector. Luminai provides AI implementation support from strategy development to system operation, and develops products that help manufacturing companies improve quality, cost and delivery through data-driven insights. The company also acquires businesses facing succession challenges and supports their transformation through technology and finance. The partnership will involve deal referrals, joint AI pilot projects using NYC's portfolio companies, back-office support for Luminai's acquired businesses, and co-investment opportunities. NYC aims to build a new ecosystem for small and medium enterprises by investing in promising startups and regional companies.